Fariba Peytam

New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study

Mehdi Adib, Fariba Peytam, Mahmoud Rahmanian-Jazi et al. · European Journal of Medicinal Chemistry · 2018 · 100 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +11

Design, synthesis and<i>in vitro</i>α-glucosidase inhibition of novel coumarin-pyridines as potent antidiabetic agents

Mehdi Adib, Fariba Peytam, Mahmoud Rahmanian-Jazi et al. · New Journal of Chemistry · 2018 · 78 citations

Medicinal Chemistry, Novel Coumarin-pyridines, Diversity Oriented Synthesis +12

Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase

Fariba Peytam, Ghazaleh Takalloobanafshi, Toktam Saadattalab et al. · Scientific Reports · 2021 · 67 citations · Full text

Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies

Mehdi Adib, Fariba Peytam, Reihaneh Shourgeshty et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 50 citations

Medicinal Chemistry, Biochemistry, Medicine +8

An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity

Fariba Peytam, Mehdi Adib, Reihaneh Shourgeshty et al. · Scientific Reports · 2020 · 49 citations · Full text